DOK2 Inhibits EGFR-Mutated Lung Adenocarcinoma is a research paper published in PLoS ONE (2013). On theSindex it has a DataRank of 0.568. It has been cited 43 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.568
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCI NIH HHS
Grant: R00 CA131488
NCI NIH HHS
Grant: R01 CA142787
NCI NIH HHS
Grant: CA-142787
NCI NIH HHS
Grant: CA-131488
NCI NIH HHS
Grant: P01 CA129243
NCI NIH HHS
Grant: R01 CA120247
NCI NIH HHS
Grant: CA-120247
NCI NIH HHS
Grant: CA-129243
NCI NIH HHS
Grant: K99 CA131488
National Institutes of Health
Grant: 5R01CA120247-09
Mutant EGF Receptor-Dependent Lung Cancer in Human Cell Lines and Transgenic Mice
National Institutes of Health
Grant: 5R01CA142787-03
Role of DOK family proteins in lung tumor suppression
National Institutes of Health
Grant: 5P01CA129243-07
Mechanisms and Modulators of Sensitivity and Resistance to EGFR Inhibitors in Lu
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals